Carcinoma of the ampulla of Vater, though a well recognised cause of obstructive jaundice, is an uncommon neoplasm. This relative rarity, along with its variable clinical presentation, often results in delayed diagnosis. However, in spite of this, carcinoma of the ampulla of Vater carries a favourable five year survival in the majority of reported series, especially when compared with pancreatic and other periampullary carcinomas. It is unusual for any patient to develop more than one malignant tumour, although it is certainly documented. We report a consecutive series of 43 patients who underwent surgery for ampullary carcinoma of whom five at some time in life had at least one other malignancy. Four have died, three from other carcinomas and one from cardiac and renal disease.
Over a 25 year period at Glasgow Royal Infirmary 43 patients (27 men and 16 women) have had a histologically proven ampullary carcinoma. The age distribution in decades (Figure 1) shows that the peak incidence is in the seventh decade. Forty one patients were diagnosed during life and two additional patients at post mortem. Five (11%) of these 43 by patients had at least one other tumour. All five patients underwent potentially curative surgery for their ampullary carcinomas. The records of all five were available for review.
In order to give some indication of the expected cancer occurrence rate in the group of 43 patients, the sex and agespecific person-years of risk were calculated from the date of diagnosis of the ampullary tumour until death, last follow-up or the development of a subsequent primary tumour. Once calculated, the age-and sex-specific incidence rates for the whole of the West of Scotland (Gillis et al., 1982) were applied to calculate the 'expected' incidence of cancer. The probability of detecting the 'observed' number of tumours was calculated by assuming that this followed a Poisson distribution with mean equal to the 'expected' value calculated as described above (Armitage, 1974) .
The details of the five patients are summarised in Table I months after her Whipple's resection from a histologically proven endometrial carcinoma with metastatic spread. At laparotomy three months prior to her death she had a hysterectomy with bilateral salpingo-oophorectomy for endometrial carcinoma of adenosquamous type. Careful examination at operation had shown no evidence of recurrence of her ampullary carcinoma. Subsequently she commenced a course of radiotherapy. However, her condition deteriorated rapidly and she died before completing the course. She had maintained good health for 38 months after her Whipple procedure.
The other patient (Table I , patient 2) initially presented with right hypochondrial pain and obstructive jaundice. Laparotomy revealed an ampullary carcinoma with enlarged retro-peritoneal lymph nodes. Transduodenal local excision biopsy with cholecystjejunostomy was performed and a solution of cyclophosphamide was left in the peritoneal cavity. Three years later she presented again with the clinical features of a large breast carcinoma including peau d'orange and axillary lymphadenopathy with gross lymphoedema of the arm. Despite the lack of histological confirmation the clinicians responsible for this aspect of her management decided on a course of treatment of local radiotherapy and chemotherapy. They were convinced throughout her illness of the clinical diagnosis of breast cancer. However, this failed to control her breast carcinoma and she finally died of metastatic disease. Post mortem examination was not carried out.
Male patients In addition to their ampullary carcinomas the three male patients developed one bronchial carcinoma, two bladder carcinomas and two carcinoid tumours. Patient (Marchal et al., 1978) was reported without reference to second malignancies. Omission of any reference to second malignancies in such a large, retrospective, multicentre study most likely implies that data on this subject were unavailable.
The stimulus for our own study was the observation by another clinician of multiple tumours in patients with ampullary cancer (C. Venables, personal communication) rather than by observing a cluster of second malignancies in our own patients. Observation of clustering may introduce bias into such a study especially where the number of second malignancies is small. It is suggested that where observation of clusters is the stimulus for such a study the patients in the cluster be omitted from the subsequent analysis. In our study all 43 patients were eligible for analysis.
Patient 3 (Table I ) had a second malignancy contemporaneous wth the diagnosis of ampullary cancer. The patient is alive and well three years after excision of both tumours. We believe the second malignancy (carcinoid of ileum) would have presented within the three years either with intestinal obstruction or metastatic disease and that the diagnosis of the second malignancy contemporaneous with the ampullary cancer has not resulted in an over diagnosing of second malignancies.
The multiple tumours in our series were confined to breast, bronchus, bladder and endometrial carcinoma and carcinoid tumours. With the exception of bronchial carcinoma and endometrial carcinoma the Iowa Group describe a quite different range of tumours. There are only two reported cases of other gastrointestinal carcinomas -one adenocarcinoma of the rectum reported by the Iowa Group (Schlippert et al., 1978) and one gastric carcinoma from another paper which they reference (Monge et al., 1964) . It would seem therefore that these patients have an increased risk of multiple malignancies which is not confined to the gastrointestinal tract.
Although the sample in our series is small there is a minimum threefold excess in the number of cancers observed over that expected. The probability values (P <0.02 and P <0.003) for the number of cases of a second primary malignancy occurring in this population of 43 patients are both significant. The analysis of the data has resulted in a probable underestimate of the degree of significance. The incidence of all forms of cancer in this geographic area was obtained and the probability of developing a second tumour of any type calculated. The relative rarity of some of the tumours reported in this study (e.g. carcinoid tumours) would in reality further decrease the probability of develop-ing such tumours as a second malignancy. The statistical analysis excluded the tumours in patients 4 and 5 which occurred prior to the diagnosis of their ampullary carcinomas and also excluded the fourth neoplasm (bronchial carcinoma) of patient 5. Male and female patients were analysed together, where separate analysis with even smaller subgroups would have increased the degree of significance.
Since there was difficulty in establishing whether the bladder carcinoma of patient 4 which occurred 6 years after his ampullary carcinoma was a new carcinoma or a recurrence of a bladder tumour treated 8 years previously, we have calculated the P value for both 4 and 5 cases of a second primary malignancy. Taking account of all these factors has only served to underestimate the P values which are already significant. From the limited literature there is a strong suggestion that patients who develop an ampullary carcinoma are at risk of developing other tumours during their lifetime. Four of the five patients whom we present in this paper are now dead. Three died from carcinomas other than that originating at the ampulla of Vater, the fourth from cardiac and renal disease.
The patients described in this paper represent a small group in statistical terms. There are numerous potential pitfalls in compiling and analysing studies of second malignancies some of which have already been mentioned -e.g., including clusters of patients if they were the stimulus to the investigations or including contemporaneous lesions discovered coincidentally at the operation for the first tumour which would not have been otherwise diagnosed before the patient died. It is also recognised that cancer rates for particular regions from which the expected number of second malignancies are calculated should be interpreted with care as cancer registration may be incomplete and vary from region to region. A larger study of this relatively unusual carcinoma would be valuable. If confirmation of our findings were obtained long term follow-up of these patients would be required. Furthermore genetic studies of patients who develop multiple tumours might show chromosomal abnormalities allowing more detailed genetic probing to be carried out.
